SO
ATNM icon

STRS Ohio’s Actinium Pharmaceuticals ATNM Stock Holding History

STRS Ohio’s Portfolio ATNM Stock Details ATNM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		– Sell
-387
Closed -$46K – 1808
2014
Q4 		$68K Hold
387
– – ﹤0.01% 1583
2014
Q3 		$78K Buy
+387
New +$76.7K ﹤0.01% 1604

Other funds holding ATNM

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
TCIM
TIAA CREF Investment Management New York $141B AUM 14.18% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
California Public Employees Retirement System
California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return

STRS Ohio's ATNM Position: Q1 2015 in Review

STRS Ohio sold out of Actinium Pharmaceuticals (ATNM) in Q1 2015, closing a stake of 387 shares — an estimated $46K sold.

STRS Ohio first reported a position in ATNM in Q3 2014 and held it in 2 quarters. The position peaked at $78K in Q3 2014. 42 funds tracked by Wall St. Rank hold ATNM as of Q1 2015.

  • STRS Ohio reported no remaining Actinium Pharmaceuticals position as of Q1 2015 after selling out during the quarter.
  • STRS Ohio sold 387 Actinium Pharmaceuticals shares in Q1 2015, an estimated $46K.
  • STRS Ohio first reported a position in Actinium Pharmaceuticals in Q3 2014 and held it in 2 quarters.
  • STRS Ohio's Actinium Pharmaceuticals position peaked at $78K in Q3 2014.
  • 42 funds tracked by Wall St. Rank held Actinium Pharmaceuticals as of Q1 2015.

Based on STRS Ohio's 13F filing for Q1 2015, filed 21 Apr 2015.